Sacubitril 49mg + Valsartan 51mg Tablets

Overview

Sacubitril with valsartan is a prescription combination tablet used to treat chronic heart failure with reduced pumping function, helping to ease symptoms and lower the chance of hospital stays.

Recommendations

• Use only under a cardiologist or physician's supervision for diagnosed heart failure.
• Typically started after stopping any ACE inhibitor and allowing a gap before the first dose.
• Take consistently as advised, alongside other prescribed heart-failure treatment.
• Attend regular check-ups so blood pressure, kidney function and potassium can be monitored.
• In the Jan Aushadhi context, this is a newer generic that may be listed but not yet stocked everywhere, so confirm availability.

Do's

• Take it at around the same time each day to keep levels steady.
• Keep follow-up appointments for blood tests as advised.
• Tell your doctor about all other medicines, including herbal and over-the-counter products.

Don'ts

• Do not take it together with or close to an ACE inhibitor.
• Do not use during pregnancy or while planning pregnancy.
• Do not stop suddenly without medical advice.

Others

Not for people with a history of severe allergic swelling (angioedema), pregnant women, or those with serious kidney or liver problems; seek urgent care for swelling of the face, lips or throat, fainting, or breathing difficulty.

Overview

Sacubitril/valsartan is an EMA-authorised prescription medicine for chronic symptomatic heart failure with reduced ejection fraction, used to reduce symptoms and the risk of hospitalisation and death.

Recommendations

• Prescribe within a specialist-guided heart-failure treatment plan.
• Allow the recommended washout period when switching from an ACE inhibitor.
• Monitor blood pressure, renal function and potassium during treatment.
• Adjust cautiously in patients who are elderly or have reduced kidney function.
• Take as a fixed regular dose alongside standard heart-failure care.

Do's

• Take the medicine consistently and as directed.
• Report dizziness, fainting or reduced urine output to your clinician.
• Disclose all concurrent medicines, including potassium supplements.

Don'ts

• Do not combine with an ACE inhibitor or use within the washout window.
• Do not use in pregnancy or breastfeeding.
• Do not co-administer with aliskiren in patients with diabetes.

Others

Contraindicated in people with a history of angioedema and in pregnancy; seek immediate help for facial or airway swelling, severe dizziness, or fainting.

Overview

Sacubitril/valsartan is an FDA-approved prescription tablet for chronic heart failure, mainly with reduced ejection fraction, to lower the risk of cardiovascular death and hospitalisation.

Recommendations

• Use under a physician's care as part of guideline-directed heart-failure therapy.
• Observe the required washout when transitioning from an ACE inhibitor.
• Have kidney function, potassium and blood pressure checked periodically.
• Take regularly and continue other prescribed cardiac medicines.
• Use lower starting approaches in patients sensitive to blood-pressure drops.

Do's

• Take the medication every day as instructed.
• Keep scheduled lab and follow-up visits.
• Inform your prescriber of all supplements and other drugs.

Don'ts

• Do not take with an ACE inhibitor or within 36 hours of one.
• Do not use if pregnant; it carries a boxed warning for fetal harm.
• Do not start if you have had angioedema with similar medicines.

Others

Carries an FDA boxed warning against use in pregnancy and is not for people with prior angioedema; get emergency care for swelling of the face or throat, severe lightheadedness, or trouble breathing.